Social Market Analytics Looks at Sentiment Surrounding Upgrades for Dendreon
Posted on January 14, 2013 at 09:18 AM EST
This week, Social Market Analytics (SMA) looks at Dendreon Corp. (NASDAQ: DNDN ), a biotechnology company with an emerging product portfolio of novel therapeutics to enhance cancer treatment options for patients, most notably Provenge for the treatment of prostate cancer. The week of January 7 yielded very positive results